Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Retina

Reducing Revitrectomy Risk

Statins are widely used for good reason. They reduce serum lipoprotein levels and treat dyslipidemias like atherosclerosis, and happen to have anti-inflammatory, anti-oxidative, anti-fibroproliferative, microvasculo-protective and neuroprotective effects too. Almost a third of the US adult population are prescribed them, and cardiologists half-joke that they should be offered as a condiment at fast-food restaurants, as they’ve shown great benefit in reducing cardiovascular mortality and morbidity. They have prevented (or delayed) millions of heart attacks since their introduction – and it looks like they have another trick up their sleeve: reducing the risk of revitrectomy in patients who have undergone vitrectomy for rhegmatogenous retinal detachment (RRD).

Read the full article now

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Mark Hillen

I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register